Intrinsic Value

The intrinsic value of Galenica AG (G70) under the Base Case is 109.15 EUR per share. Compared with the current market price of 98.1 EUR, the stock appears Undervalued by 10% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

G70 Intrinsic Value
€109.15
Undervaluation 10%
Intrinsic Value
Price €98.1
Alert me when G70 is below its intrinsic value
Today €87.32 · 11.0% below the current price

G70 is more expensive than usual. Still undervalued, but the discount was larger on 93% of days in the past 5 years.

Alternatives to G70

Fundamental Analysis

What Galenica Does

Health Care

Galenica AG is a Swiss healthcare company focused on moving medicines and health products to the people and businesses that need them. It runs a large pharmacy network, distributes prescription drugs and over-the-counter products, and supplies medicines, medical goods, and related services to pharmacies, doctors, hospitals, and care institutions in Switzerland.

Headquarters
Switzerland CH
Employees
6 577
IPO date
Apr 7, 2017
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Galenica insiders rarely trade

Insider trading · Last trade on Aug 23, 2026

Sold CHf0 Nobody sold
Bought CHf4.9k 1 insider
Trades by date
Open insider trading

Past 12 months

Continue G70 Research

Decided on Galenica? Get an email when G70 reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one G70 stock?

The intrinsic value for Galenica AG (G70) under the Base Case is 109.15 EUR.

Is G70 stock undervalued or overvalued?

Compared with the current market price of 98.1 EUR, the stock appears Undervalued by 10% .

How reliable are our estimates? See how past valuations played out
Back to Top